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Evidence for a Bacterial Lipopolysaccharide-Recognizing G-Protein-
Coupled Receptor in the Bacterial Engulfment by Entamoeba
histolytica
Matthew T. Brewer, Prince N. Agbedanu, Mostafa Zamanian, Tim A. Day, Steve A. Carlson
Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, USA
Entamoeba histolytica is the causative agent of amoebic dysentery, a worldwide protozoal disease that results in approxi-
mately 100,000 deaths annually. The virulence of E. histolyticamay be due to interactions with the host bacterial flora,
whereby trophozoites engulf colonic bacteria as a nutrient source. The engulfment process depends on trophozoite recog-
nition of bacterial epitopes that activate phagocytosis pathways. E. histolytica GPCR-1 (EhGPCR-1) was previously recog-
nized as a putative G-protein-coupled receptor (GPCR) used by Entamoeba histolytica during phagocytosis. In the present
study, we attempted to characterize EhGPCR-1 by using heterologous GPCR expression in Saccharomyces cerevisiae. We
discovered that bacterial lipopolysaccharide (LPS) is an activator of EhGPCR-1 and that LPS stimulates EhGPCR-1 in a
concentration-dependent manner. Additionally, we demonstrated that Entamoeba histolytica prefers to engulf bacteria
with intact LPS and that this engulfment process is sensitive to suramin, which prevents the interactions of GPCRs and
G-proteins. Thus, EhGPCR-1 is an LPS-recognizing GPCR that is a potential drug target for treatment of amoebiasis, espe-
cially considering the well-established drug targeting to GPCRs.
Entamoeba histolytica is an important cause of amoebic dys-entery (1). E. histolytica infection often manifests as colitis,
but trophozoites can also gain access to the systemic circulation
and result in liver or brain abscesses (2, 3). The majority of
infections are asymptomatic (4), and the host factors that de-
termine the pathological severity of infection have not been
well characterized.
The virulence of E. histolyticamay be due to interactions with
the host bacterial flora. Coculture with bacteria can restore amoe-
bic virulence in E. histolytica cell lines attenuated through serial
passage (5, 6), and this effect is related to an upregulation of genes
associated with enhanced phagocytosis (7). Specifically, E. histo-
lytica exhibits enhanced adherence and cytotoxic capabilities fol-
lowing engulfment of enteropathogenic bacteria (8). E. histolytica
is also dependent on colonic bacteria as a nutrient source for tro-
phozoites. Prior to the advent of selective medium, trophozoites
could be grown only in culture medium containing bacteria (9).
Although trophozoites are now routinely grown in bacteria-free
culture medium, exposure to Escherichia coli enhances their
growth (8). However, while it is clear that E. histolytica regularly
engulfs bacteria, the specific bacterial epitopes recognized by
amoebic receptors are unknown.
Phagocytosis is a stepwise process that is initiated by activation
of receptors that bind an extracellular target and ultimately acti-
vate cytoskeletal rearrangements. The phagocytic ability is essen-
tial for the pathogenesis of amoebiasis and is strongly correlated
with virulence; Entamoeba dispar, a nonpathogenic species, is less
efficient at engulfing bacteria (10, 11). While many studies have
established the importance of phagocytosis in amoebic pathogen-
esis, relatively few receptors mediating this process have been
identified. The transmembrane kinase TMK96 is involved in
erythrophagocytosis, while TMK39 is a cholesterol receptor that
may also mediate bacterial engulfment (12, 13). In metazoan
phagocytes, G-protein-coupled receptors (GPCRs) have been
found to initiate the phagocytosis of bacteria (14). GPCRs are
transmembrane receptors that act as guanine nucleotide exchange
factors upon binding extracellular ligands. Recent studies by
Bosch et al. described G-protein signaling in E. histolytica; how-
ever, the receptors that interact with amoebic G-proteins are not
well established (15). Picazarri et al. described GPCR-1 of E. his-
tolytica (EhGPCR-1), a putative GPCR associated with vesicular
trafficking of proteins that localize to phagocytic cups (16).
EhGPCR-1 is highly expressed in pathogenic E. histolytica but not
in E. dispar (www.amoebadb.org; version 2.0), possibly account-
ing for the differential engulfment of bacteria by these divergent
Entamoeba species (17). The ligand for EhGPCR-1 had not been
identified prior to the present study.
We hypothesized that since EhGPCR-1 has a putative role in
the initiation of phagocytosis, it may recognize bacterial prey that
are an essential nutrient source and potentiators of virulence forE.
histolytica. In the present study, we used a heterologous Saccharo-
myces cerevisiae expression system to screen bacterial components
for their ability to activate EhGPCR-1. In addition, we tested the
ability of E. histolytica trophozoites to selectively engulf bacteria
based on the presence of a bacterial component putatively identi-
fied as a ligand for EhGPCR-1.
MATERIALS AND METHODS
Creation of the yeast expression vector encoding EhGPCR-1.DNA en-
coding EhGPCR-1 (accession number AY880672) was synthesized by
GeneScript via codon optimization for yeast expression. The gene was
cloned into the pUC57 vector, and the cDNA was amplified with forward
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and reverse primers, adding restriction sites for NcoI and BamHI (5=-GC
CATACCATGGATCAATCATTCGGTAATCAA-3= and 5=-GCCATAGG
ATCCTTAAGTCAAGTTAATTTCTCTTGAA-3=) to the 5= and 3= ends
of the amplicon, respectively. Purified amplicons and the linearized yeast
expression vector Cp4258, which contains a leucine auxotrophic marker
and encodes ampicillin resistance (18, 19), were codigested withNcoI and
BamHI restriction endonucleases. The EhGPCR-1 gene was then ligated
into Cp4258 by using T4 DNA ligase (New England BioLabs). The result-
ing plasmid was transformed into E. coli, and individual clones were se-
lected and aerobically grown overnight at 37°C in Luria-Bertani (LB)
broth containing 32 g/ml ampicillin. Plasmid DNA was purified using a
HiSpeed plasmid minikit (Qiagen), and inserts were sequenced to con-
firm the cDNA orientation and fidelity.
Transfection of yeastwith the EhGPCR-1 expression vector. Saccha-
romyces cerevisiae strain CY 18043 (J. Broach, Princeton University) was
used as the yeast recipient, since this strain is a histidine auxotroph that
exhibits histidine prototrophism upon GPCR activation, even for exoge-
nous receptors (18, 19). Nontransfected CY 18043 yeast was grown in
yeast extract-peptone-dextrose medium supplemented with all essential
amino acids. Cells at mid-log phase (optical density at 600 nm [OD600] of
0.3 to 0.5) were transfected with 1 g cDNA construct or 1 g empty
vector (mock transfectants) in the presence of 200g salmon spermDNA
(Invitrogen) and lithium acetate (100 mM; Sigma-Aldrich). Yeast cells
were then incubated at 30°C and heat shocked at 42°C for 15 min. Cells
were placed on leucine-deficient medium (1 yeast nitrogen base [YNB;
Difco], 1 yeast synthetic dropout medium supplement without leucine
[Sigma], 10 mM ammonium sulfate [Sigma], and 50% glucose) to select
for transfection of Cp4258 with the EhGPCR-1-carrying plasmid. Trans-
fectants were verified by isolating plasmids (Promega), and colonies ex-
pressing EhGPCR-1 were verified by PCR prior to the functional assay.
Yeast growth assay. Since the Cp4258 vector encodes leucine proto-
trophism, leucine-deficient medium was inoculated with yeast cells ex-
pressing EhGPCR-1 or mock-transfected yeast cells that were grown at
30°C to an OD600 of 1. Cells were washed three times with leucine/histi-
dine-deficient medium (1 YNB [Difco], 1 yeast synthetic dropout
medium supplement lacking leucine and histidine [Sigma], 10 mM am-
monium sulfate [Sigma], 50% glucose, 50mM4-morpholinepropanesul-
fonic acid [pH 6.8]) and resuspended in 1 ml leucine/histidine-deficient
medium to a density of 15 to 20 cells/l. Approximately 3,000 cells were
added to each well of 96-well plates containing the same medium along
with test agonists in a total volume of 200l. Cells were grown at 30°C for
approximately 24 h. Initial and final OD600 values were determined with a
spectrophotometer to determine growth of the yeast cells.
Agonist and antibody binding studies. E. coli (K-12 strain; Sigma-
Aldrich) and lipopolysaccharide (LPS)-free rough strain E. coli MG1655
(K-12 derivative; N. Cornick, Iowa State University) were grown aerobi-
cally overnight in LB broth at 37°C. To produce bacterial lysates, cultures
were incubated for 10 min at 100°C. Purified LPS from E. coli O111:B4
(Sigma-Aldrich) was also used as a test agonist.
Serial dilutions of whole bacteria, lysate, or LPSwere added to leucine/
histidine-deficient medium for the yeast growth assay. Antibody-medi-
ated inhibition of GPCR activation was performed by coincubating test
agonists in 200 l medium with 25 l equine anti-LPS antiserum (1:10
titer; MG Biologics, Ames, IA) in the absence or presence of proteinase K
(50 g/ml; 3 h at 37°C; Qiagen).
Bacterial engulfment assay. Bacteria were fluorescently labeled by
growing 8 108 CFU in 1 ml of LB broth (Invitrogen) containing 10 g
fluorescein isothiocyanate (FITC; Sigma-Aldrich). Cells were washed
three times with and resuspended in M199 medium (Gibco) supple-
mented with 25 mMHEPES and 5.7 mM cysteine (M199s).
E. histolyticaHM1 trophozoites (courtesy ofWilliam Petri, University
of Virginia) were grown under anaerobic conditions at 37°C in TYI me-
dium (9). Trophozoites were harvested by centrifugation for 5 min at
1,000 rpm, and 2.5 105 trophozoiteswere added to eachwell of a 24-well
tissue culture dish in 500l of TYI medium. Cells were allowed to adhere
to the wells for 1 h at 37°C under anaerobic conditions. For engulfment
inhibition experiments, trophozoites were allowed to adhere and then
were incubated with suramin (Sigma-Aldrich) for 1 h. Each well was
washed twice with prewarmed M199s medium and inoculated with
8.75 106 CFU of bacteria in a final volume of 500l of M199s medium.
Bacteria and amoebae were coincubated at 37°C for 25 min in the pres-
ence or absence of suramin. The medium was aspirated, and 500 l ice-
cold 110 mM D-galactose was added to each well to detach trophozoites.
Cells were pelleted by centrifugation for 5 min at 1,000 rpm and washed
with 500 l ice-cold 110 mM D-galactose. Cells were then fixed in 2%
paraformaldehyde for 20 min at 37°C. Paraformaldehyde was neutralized
with 50 mM ammonium chloride, and cells were pelleted and resus-
pended in phosphate-buffered saline. Aliquots (5 l) were fixed with
Fluoromount-G mounting medium (Southern Biotech, Birmingham,
AL) on a microscope slide. These specimens were examined by fluores-
cence microscopy on an Olympus BX51 microscope with a UPlan F1
40/0.75 objective equipped with an HBO lamp and dichroic FITC illu-
mination filter for visualization of engulfment of bacteria by trophozoites.
For flow cytometry experiments, at least 10,000 amoebic cells were
analyzed for the presence of internalized bacteria on a Becton Dickinson
FACScalibur apparatus or aMiltenyiMACSQuant instrument (excitation
wavelength of 488 nm). Data were acquired by using CellQuest software
(BD Biosciences) or MACSQuant software (Miltenyi Biotech) and ana-
lyzed by using the FlowJo flow cytometry analysis software (Tree Star,
Inc., Ashland, OR).
Search for other GPCRs in E. histolytica. With our GPCR search
algorithm designated the transmembrane-focused support vector ma-
chine (TMf-SVM), we explored the E. histolytica genome for GPCR-like
sequences, as previously described for other eukaryotes (20). Expression
of these sequences was then analyzed within the Entamoeba database
(www.amoebadb.org; version 2.0), using data from expressed sequence
tags (ESTs) and microarrays.
Statistical analyses. Statistical analyses were performed using an anal-
ysis of variance with Scheffe’s F test for multiple comparisons. StatView
software was used.
RESULTS
EhGPCR-1 activation by bacterial lysates.To determine if EhGPCR-1
recognizes bacterial components, we monitored the response of
the receptor to bacterial lysates in a histidine-auxotrophic yeast
heterologous expression assay (18, 19). In this assay, the GPCR of
interest is expressed in histidine-auxotrophic S. cerevisiae cells en-
gineered to lack their native GPCRs.When the expressedGPCRof
interest is stimulated by its cognate ligand or agonist, a promiscu-
ous GPCR-inducible pheromone pathway is activated, which
leads to downstream expression of the His3 reporter gene. His3
encodes de novo histidine synthesis enzymes, and thus His3 ex-
pression provides the ability to grow on histidine-deficientmedia.
As a result, heterologous receptor activation can by quantified by
spectrophotometric analysis of yeast growth. Receptor activation
is calculated by comparing ligand-induced yeast growth to growth
of yeast cells transfected with empty vector and exposed to the
same ligand or agonist.
Application of E. coli K-12 lysates to EhGPCR-1-expressing
yeast produced a significant increase in yeast growth; specifically,
the EhGPCR-1-expressing yeast cells were stimulated more than
1,400% compared to mock-transfected yeast cells (Fig. 1). This
growth was markedly attenuated by the addition of anti-LPS an-
tibodies, and the effect of the anti-LPS antibodies was abrogated
by proteinase K. Addition of a rough strain of E. coli K-12 that
lacks the outer O-antigen of LPS (21) stimulated EhGPCR-1 to a
significantly lesser extent. Histidine prototrophism was not ob-
served when EhGPCR-1-expressing yeast cells were exposed to a
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panel of biogenic amines (histamine, serotonin, dopamine, epi-
nephrine, and norepinephrine; 0 to 100 mM) that are classic
GPCR agonists or antagonists inmammals (data not shown). Spe-
cifically, these biogenic amineswere used in early deorphanization
attempts, since they are important GPCR ligands in a variety of
organisms.
Concentration-dependent activation of EhGPCR-1 by LPS.
Since EhGPCR-1 was putatively activated by LPS, we examined
the ability of LPS to stimulate EhGPCR-1 in a concentration-de-
pendent manner. EhGPCR-1-expressing yeast cells were incu-
bated with various concentrations of purified LPS isolated from E.
coli O111:B4 and, again, yeast growth in histidine-free medium
was measured as an indicator of EhGPCR-1 activation. LPS acti-
vated EhGPCR-1 in a concentration-dependent manner, with a
50% effective concentration (EC50) of 15 nM (Fig. 2).
Preferential engulfment of LPS-expressing E. coli by Ent-
amoeba histolytica trophozoites. To determine if E. histolytica
trophozoites selectively engulf bacteria based on the presence of
LPS, we compared the engulfment of E. coli K-12 and a rough
isostrain of E. coli that lacks intact LPS. Bacteria were fluorescently
labeled with FITC and coincubated with E. histolytica HM1 tro-
phozoites. Trophozoites were washed to remove bacteria that
were not engulfed or attached, and the number of E. histolytica
trophozoites containing bacteria was quantitated by flow cytom-
etry. Phagocytosis assays revealed that 23.2% of trophozoites con-
tained E. coli K-12, while only 3.8% of trophozoites engulfed the
rough strain. This represented a80% reduction in the bacterial
engulfment capability of E. histolytica (Fig. 3). Because no EhG-
PCR-1-specific drugs are known, we confirmed the role of G-pro-
tein signaling in engulfment of bacteria by conducting phagocy-
tosis assays in the presence of suramin, which uncouples GPCR
and G-proteins (22). Suramin blocked phagocytosis in a concen-
tration-dependent manner, with a 50% inhibitory concentration
(IC50) of approximately 80 M (Fig. 4).
Identification of GPCR-like sequences in the E. histolytica
genome. In order to assess the potential role of otherGPCRs in the
suramin-mediated effects on phagocytosis of bacteria, we investi-
gated the possible existence of other E. histolyticaGPCRs. Using a
search algorithm that mines occult GPCR-encoding sequences
from nonmammalian genomes by targeting transmembrane sig-
natures (20), we uncovered eight sequences encoding putative
GPCRs. As summarized in Fig. 5, EST and microarray studies
(www.amoebadb.org) revealed that none of these receptors ap-
peared to be expressed in E. histolytica. EhGPCR-1 is expressed in
E. histolytica but not in E. dispar.
DISCUSSION
Previous work indicated that EhGPCR-1 is linked to phagocytic
pathways in E. histolytica (16). The goal of the present studywas to
characterize EhGPCR-1 by determining its cognate ligand in a
FIG 1 EhGPCR-1 is stimulated by E. coli K-12 lysate. EhGPCR-1 was ex-
pressed in histidine-auxotrophic yeast cells in which the activation of GPCRs
stimulates a histidine synthesis pathway, producing stimulation of yeast
growth in media lacking histidine. Receptor activation is expressed as the per-
cent yeast growth relative to mock-transfected yeast. Data are expressed as
means standard errors of the means. For bacteria only, n 6; for antibody
experiments, n 3. *, P 0.05 versus vehicle.
FIG 2 Bacterial LPS activates EhGPCR-1 in a concentration-dependent man-
ner, with an EC50 of 15 nM. The concentrations on the x axis were estimated
based on projection of a molecular mass of 2,000 g/mol for LPS. The open
triangle represents the response of mock-transfected yeast cells to the highest
concentration of LPS used. Each data point represents the mean  standard
error of the mean for three independent experiments. *, P 0.05 versus mock
transfected.
FIG 3 E. histolytica preferentially engulfs E. coli cells expressing LPS. The data
are the mean  standard error of the mean percentage of trophozoites con-
taining bacteria after 25 min of coincubation of E. histolytica with E. coli, and
10,000 trophozoites were counted for each sample. The data represent three
independent experiments with three replicates under each condition. *, P 
0.05 versus rough E. coli.
GPCR in Entamoeba histolytica
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heterologous expression system and to confirm the functional ac-
tivity of the ligand in E. histolytica trophozoites.
GPCRs are cell surface receptors that sense the extracellular
environment and are activated by a variety of ligands, such as
catecholamines, peptides, lipids, carbohydrates, etc. GPCRs are
excellent drug targets, reflected by the fact that 30 to 50% of cur-
rently marketed drugs target these receptors (23, 24). While
GPCRs have been well studied in vertebrates, the study of their
role in E. histolytica physiology is only in its infancy. E. histolytica
expresses heterotrimeric G-proteins, which have been shown to
modulate pathogenic processes, yet few receptors that interact
with theseG-proteins have been identified (15). A reviewbyBosch
and Siderovski indicated thatE. histolyticaG-proteins lack homol-
ogy to mammalian G-proteins (25), suggesting that GPCRs have
not been identified in E. histolytica because of inadequacies in
genomic search tools for divergent receptors. Classic GPCR ago-
nists, such as histamine and serotonin, canmodulate E. histolytica
phagocytosis and virulence in a mouse model, but their receptors
remain unidentified (26, 27). EhGPCR-1 did not respond to these
ligands in our yeast assay (data not shown). Furthermore, our
genomic search tool did not uncover any other GPCRs expressed
byE. histolytica (Fig. 5). In the absence of anotherGPCRexpressed
by E. histolytica (that could be targeted as a control, to rule out
collateral effects) and our inexperiencewith hairpinRNA,wewere
unable to perform the appropriate control experiments via RNA
interference-based knockdown (28) of EhGPCR-1 expression.
The present study utilized a novel yeast auxotroph assay for
screening GPCRs against potential ligands and agonists. This ap-
proach has recently been applied to GPCRs from parasitic hel-
minths (18, 19) and may represent a valuable tool for the study
of protozoan receptors, since culture of these microbes is often
difficult. By utilizing this approach, we demonstrated that
EhGPCR-1 is activated by a bacterial component of E. coli. This
activation was abrogated in the presence of anti-LPS antibodies
or a generic GPCR inhibitor. Purified LPS induced concentra-
tion-dependent EhGPCR-1 activation, although this response
was not as robust as the response to bacterial lysates. Structural
variances between LPS from E. coli K-12 and E. coli O111:B4
might explain differences in receptor activation. Alternatively,
additional bacterial components may be required for maximal
FIG 4 Suramin inhibits engulfment of bacteria by E. histolytica in a concen-
tration-dependentmanner, with an IC50 of approximately 80M.Data are the
mean percentage ( the standard error of the mean) of trophozoites that
contained bacteria after 1 h of coincubation with E. coli. Data are from three
independent experiments, with each repeated in triplicate. *, P 0.05 versus
suramin-free control.
FIG 5 Identity of eight putative and novel E. histolytica GPCRs uncovered when we used TMf-SVM (20). Expression of each receptor in E. histolytica is also
shown, as determined from EST andmicroarray studies (www.amoebadb.org). EhGPCR-1 is presented in the bottom row. The DRYmotif (29) is shown in bold
and underlined in the sequence for XP_65721.1/EDI_148210.
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occupancy of EhGPCR-1. Further research is needed to unveil
the unique pharmacologic aspects of EhGPCR-1 in E. histo-
lyticawith respect to agonist affinity and binding cooperativity.
EhGPCR-1 may represent a new GPCR subtype, since an NCBI
motif database search revealed that it is most closely related to
the MIG-14-Wnt-bd superfamily of proteins and it lacks the
E/DRY and NPXXY motifs found in class A-type GPCRs (29).
Interestingly, one of the nonexpressed E. histolytica GPCRs
contains a DRY motif (Fig. 5).
Based on the results of our yeast expression assay, we hypoth-
esized that E. histolytica initiates bacterial engulfment after recog-
nizing bacterial LPS. Phagocytosis assays demonstrated a 80%
reduction in the number of trophozoites containing bacteria
when the bacterial prey lacked O-antigen, the outermost layer of
LPS. This result is supported by previous research indicating that
E. histolytica primarily engulfs Gram-negative pathogens (30).
Other investigators have also demonstrated selective engulfment
of bacteria by amoebae based upon bacterial O-antigen (31, 32).
Therefore, other taxa of protozoa potentially express similar re-
ceptors for bacterial recognition. EhGPCR-1-mediated preferen-
tial feeding behaviors on bacteria may also lead to disruptions in
the intestinal microbiota, which are observed during infection
with E. histolytica (33). The composition of the intestinal flora is
likely to be a factor allowing E. histolytica colonization of the gut,
and the role of EhGPCR-1 in this process is a current line of re-
search in our laboratory.
In summary, this study demonstrates the utility of a heterologous
yeast expression system in the characterization of EhGPCR-1, a
GPCR putatively used in phagocytosis by pathogenic E. histolytica.
EhGPCR-1 is activated by bacterial LPS, suggesting that this GPCR
maybeused to initiatephagocytosis upon the recognitionofbacterial
prey. Functional studies supported the roleofLPS inengulfmentofE.
coli by E. histolytica. EhGPCR-1 is the first GPCR to be characterized
inE. histolytica, and itmay represent an important chemotherapeutic
target in thispathogen.While thismaybe theonlyGPCRexpressed in
E. histolytica despite the unexplained presence of nonexpressed
GPCR-encodinggenes, otherprotozoanGPCRsmay represent inno-
vativedrug targets, and their roles in regulatingprotozoanphysiology
merit further investigation.
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